MYO technology is simple
Once inside the cell, the cell’s protein production machinery takes over; muscle cells begin synthesizing and secreting antibody molecules. The antibodies can then readily access the bloodstream through the abundant small blood vessels in muscle tissue, and from there travel to other parts of the body to perform their disease-fighting functions.
MYO technology requires fewer treatments
And because the antibody DNA is stable in muscle cells for several months, antibodies are continually produced during this period, resulting in fewer treatments than with traditional antibody delivery.